RDVT: Fundamentals Strong, but $90 Target Requires Faith in Reacceleration

What happened

Red Violet's stock has surged roughly 95% over the past six months, leaving the cautious WAIT stance from the DeepValue master report dated February 2026 far behind. The company's fundamentals remain robust: revenue grew ~20% YoY, contractual mix improved to 78% from 75%, and adjusted EBITDA margins stayed elevated near 39%. A new Seeking Alpha analysis rates the stock a buy with a $90 target, arguing the multiple is still below faster-growing peers despite the run. However, the master report's concerns about thin trading liquidity, housing cyclicality in the non-FOREWARN real estate vertical, and the lack of named public-sector wins via the GSA/Carahsoft channel have not been fully resolved. The gap between the two views hinges on whether growth can reaccelerate beyond 23% and whether public-sector contracts materialize, which would justify further multiple expansion.

Implication

The Seeking Alpha buy rating and $90 target rest on re-acceleration beyond 23% growth, but the master report's base case only supported $46 at the time, suggesting the current price already embeds significant optimism. Investors should focus on whether contractual mix remains above 75% and whether the GSA/Carahsoft channel finally yields named agency wins, which are the key catalysts for de-risking the growth story. The stock's thin trading liquidity amplifies downside risk if quarterly results disappoint, as evidenced by the 15% drawdown in early 2026. While the balance sheet is net cash and buybacks provide some cushion, the $18.9M remaining authorization is small relative to market cap, and management's buyback pace has been minimal. Prudent investors may wait for a pullback toward the $55 trim level from the master report or for concrete public-sector evidence before adding, rather than chasing the momentum at $70+.

Thesis delta

The core thesis—durable subscription growth, high margins, and optionality in public sector—remains intact, but the investment case has shifted from 'undervalued with room to run' to 'priced for flawless execution.' The DeepValue master report's WAIT was based on no margin of safety at $41; with the stock now around $70 after a 95% rally, that margin of safety has further eroded even as growth metrics ticked up modestly. Consequently, the bullish $90 target appears to depend on multiple expansion that the master report did not deem justified absent evidence of public-sector traction and sustained >20% growth.